Latest news
BIO-key to host Q2 investor call and webcast - BitgetBitget · Fri, 07 Aug 2026 12:25:07 GMTCLIMB BIO INC : TRUIST SECURITIES RAISES TARGET PRICE TO $25 FROM $17 - BitgetBitget · Fri, 07 Aug 2026 11:54:35 GMTPAPA JOHNS : DEUTSCHE BANK CUTS TARGET PRICE TO $27 FROM $35 - BitgetBitget · Fri, 07 Aug 2026 11:33:30 GMTHoriba lifts FY2028 targets, sees net sales JPY 460 billion and operating profit JPY 90 billion - BitgetBitget · Fri, 07 Aug 2026 08:07:59 GMTUS Stock Market Movement | Cardiovascular Pharmaceutical Company Braveheart Bio (BRVE.US) Debuts on the US Stock Market, Shares Surge Over 75% After Opening - BitgetBitget · Thu, 06 Aug 2026 17:33:20 GMTAumovio H1 FY26 adjusted EBIT drops 39.8% to EUR 157 million; sales fall 8.9% to EUR 8.65 billion - BitgetBitget · Thu, 06 Aug 2026 17:19:03 GMTBiotech IPO boom continues! Cardiovascular drug company Braveheart (BRVE.US) increases fundraising to $382.5 million, issue price exceeds upper end of guidance - BitgetBitget · Thu, 06 Aug 2026 09:10:28 GMTBraveheart Bio Shares Expected to Start Trading on Nasdaq Global Market on Aug. 6 Under Ticker 'BRVE' - BitgetBitget · Thu, 06 Aug 2026 03:22:05 GMT